dr. Tom van der Hulle
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cabozantinib Dose Skipping as an Alternative to Dose Reductions (NCT07077161) | dr. Tom van der Hulle | 2026-01-01 |
| The Pharmacological Effects of Using Cabozantinib With a Light Breakfast (NCT05263245) | dr. Tom van der Hulle | 2023-05-25 |
Track dr. Tom van der Hulle automatically
Every clearance here is in the API, with alerts when new ones post.